Trillium

Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors

Retrieved on: 
星期一, 九月 12, 2022
CD47, Therapy, Novosibirsk State University of Economics and Management, COVID-19, Partner, U.S. Securities and Exchange Commission, Company, Acquisition, Form 10-K, Economics, Harvard Business School, Industry, Bain & Company, MBA, BS, Board of directors, Private Securities Litigation Reform Act, Doctor of Philosophy, Failure, Board, SAN, GLOBE, SEC, DEM, University, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Cancer, Executive, Pfizer, Management, Pharmaceutical industry, Trillium

Dr. Skvarka is an accomplished biopharmaceutical executive bringing over three decades of extensive operational, strategic and financial expertise to Zentalis.

Key Points: 
  • Dr. Skvarka is an accomplished biopharmaceutical executive bringing over three decades of extensive operational, strategic and financial expertise to Zentalis.
  • We are excited to welcome Jan, an experienced life sciences leader, to our Board of Directors, said Dr. Kimberly Blackwell, Chief Executive Officer of Zentalis.
  • I am thrilled to be joining Zentalis passionate team at this pivotal time in the Companys trajectory, said Dr. Skvarka.
  • Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers.

Leukemia Therapeutics Global Market Report 2022: A $20+ Billion Market in 2026 - Long-term Forecast to 2031 - ResearchAndMarkets.com

Retrieved on: 
星期一, 九月 12, 2022
Pharmaceutical, Health, Oncology, GlaxoSmithKline, Therapy, Chronic lymphocytic leukemia, Immunotherapy, Lupin Limited, Texas Homecare, Prevalence, Exelixis, Asia-Pacific, Takeda Pharmaceutical Company, Organization, Acquisition, National, Growth, Leukemia, MorphoSys, Industry, Patient, Cancer, Acute leukemia, Bone marrow, Acute myeloid leukemia, Amgen, Pfizer, Bristol Myers Squibb, AbbVie, Celgene, Lymphatic system, Immune system, Hospital, National Cancer Institute, Medical device, Pharmaceutical industry, Oil, Trillium

The leukemia therapeutics market consists of sales of the leukemia therapeutics by entities (organizations, sole traders, and partnerships) that are used for the treatment of leukemia.

Key Points: 
  • The leukemia therapeutics market consists of sales of the leukemia therapeutics by entities (organizations, sole traders, and partnerships) that are used for the treatment of leukemia.
  • The regions covered in the leukemia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The leukemia therapeutics market research report is one of a series of new reports that provides leukemia therapeutics market statistics, including leukemia therapeutics industry global market size, regional shares, competitors with a leukemia therapeutics market share, detailed leukemia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the leukemia therapeutics industry.
  • Global Leukemia Therapeutics Market, Segmentation By Type Of Leukemia, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Galileo Is Now a Participating Provider for Wellcare Medicare Advantage Members in New York

Retrieved on: 
星期二, 八月 30, 2022
Partnership, Centene Corporation, Medicaid, 1Life Healthcare, CEO, Technology, Fortune 500, Medicare Advantage, Time, Trillium, PDP, SVP, LinkedIn, Diagnosis, Hearing, Harvard University, Depression, PPO, Instagram, Medicare, Hypertension, Population, Twitter, Fidelis Care, Allwell Uwazuruike, HMO, WellCare, Diabetes, Health, Transport, Hospital Insurance and Diagnostic Services Act, Patient, Epocrates, Health insurance, Hospital, Galileo Galilei, Flex

NEW YORK, Aug. 30, 2022 /PRNewswire/ -- Wellcare and Galileo today announced a partnership giving Wellcare's Medicare Advantage members in New York in-network access to Galileo's expert primary and multispecialty care providers.

Key Points: 
  • NEW YORK, Aug. 30, 2022 /PRNewswire/ -- Wellcare and Galileo today announced a partnership giving Wellcare's Medicare Advantage members in New York in-network access to Galileo's expert primary and multispecialty care providers.
  • Galileo delivers faster and more accurate diagnosis and treatment, resulting in lower cost of care and better outcomes.
  • We're thrilled to work with Wellcare to bring a new standard of healthcare to Medicare Advantage members in New York."
  • For more than 20 years, Wellcare has offered a range of Medicare products, including Medicare Advantage and Medicare Prescription Drug Plans (PDP), which offer affordable coverage beyond Original Medicare.

U.S. Gain Hires Ty Severson and Ashley Duplechien to Support RNG Supply Growth

Retrieved on: 
星期二, 八月 23, 2022
Cargill, CFP, Avant, RFS, Carbon, Trillium, National Renewable Energy Laboratory, Character, Power, Farmer, Hydrogen, Organization, Severson, Goal, LCFS, GLOBE, Electricity, RNG, CNG, Farm, RIN, Business, Natural gas, Transport, Industry, Record, Wind, Marketing, Public policy, Renewable energy

Within these roles, Severson and Duplechien will spearhead growth and optimization across U.S. Gains expanding portfolio of RNG projects.

Key Points: 
  • Within these roles, Severson and Duplechien will spearhead growth and optimization across U.S. Gains expanding portfolio of RNG projects.
  • From cultivating new relationships to leveraging existing partnerships, together they will grow U.S. Gains footprint across RNG marketsidentifying new opportunities to connect supply into end-uses beyond transportation.
  • Severson brings over twenty years experience in energy and renewable markets to U.S. Gain.
  • The RNG space today feels much like the power markets did following deregulation in the late 90s to early 2000s, noted Ty.

Trillium Gold Appoints Luke Norman as Executive Chair

Retrieved on: 
星期一, 八月 22, 2022
Mining, Evolution, CEO, NYSE, Legislation, Perception, Insurance, OTCQX, Accident, Interim, Board, TGM, TSX Venture Exchange, Gold, TSX, Canaccord Genuity, GLOBE, Intention, Company, News, Director, Acquisition, Industry, Growth, Security (finance), Cryptocurrency, Management, Risk management, Trillium, Confederation Lake Water Aerodrome

VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is very pleased to announce that Mr. Luke Norman has been appointed Executive Chair of the Companys Board of Directors effective immediately.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is very pleased to announce that Mr. Luke Norman has been appointed Executive Chair of the Companys Board of Directors effective immediately.
  • He is credited with the discovery and advancement to production of notable projects in North America; as co-founder of Gold Standard Ventures Corp., a TSX and NYSE listed gold explorer-developer, and more recently as Co-founder and Chair of U.S. Gold Corp., Chair of Silver One Resources, and CEO of Leviathan Gold, Ltd.
    Mr. Norman has been a significant investor in Trillium Gold since early 2020.
  • Russell Starr, President and CEO of Trillium Gold stated, Luke has a distinguished reputation in the mining industry for exemplary leadership, governance and steadfast commitment to building value for shareholders.
  • Mr. Starr has stepped down from his position as Interim Chair and remains President and CEO of the Company.

Global Automotive Cybersecurity (Network, Application, Endpoint, Wireless, Cloud) Markets Report 2022

Retrieved on: 
星期五, 八月 19, 2022
Software, Technology, Continental, RAT, Accident, Aptiv, Infineon Technologies, Harman International, Lear Corporation, NortonLifeLock, Intelligence, Intel, V2X, Organization, Continental AG, Argus Cyber Security, Internet, Electronics, Cyberattack, Tesla, LG Electronics, Industry, Growth, Acquisition, Medical device, Weapon, Road, Trillium, Cisco Systems

DUBLIN, Aug. 19, 2022 /PRNewswire/ -- The 'Automotive Cybersecurity Global Market Report 2022' report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 19, 2022 /PRNewswire/ -- The 'Automotive Cybersecurity Global Market Report 2022' report has been added to ResearchAndMarkets.com's offering.
  • The main types of automotive cybersecurity are network security, application security, endpoint security, wireless security, and cloud security.
  • The regions covered in the automotive cybersecurity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The automotive cybersecurity market research report is one of a series of new reports that provides automotive cybersecurity market statistics, including automotive cybersecurity industry global market size, regional shares, competitors with an automotive cybersecurity market share, detailed automotive cybersecurity market segments, market trends and opportunities, and any further data you may need to thrive in the automotive cybersecurity industry.

Trillium Community Health Plan Partners with Unite Us to Address Social Determinants of Health for Oregon Health Plan Members

Retrieved on: 
星期五, 八月 19, 2022
Trillium, Faith Divides Us – Death Unites Us, CCO, CEO, Technology, OHP, Oregon Health Plan, Connect, State network, Health equity, Instagram, Linn, Twitter, Partnership, Health, LinkedIn, Housing, HITRUST, Organization, Health insurance, Public relations, Risk management, Facebook, The Oregonian

EUGENE, Ore., Aug. 19, 2022 /PRNewswire/ -- Trillium Community Health Plan (Trillium) is proud to announce its partnership with Unite Us, a leading technology company connecting health and social care services, to further enhance the health plan's ability to collaborate with providers and local community-based organizations to provide integrated healthcare services for Oregon Health Plan (OHP) members in Lane, western Linn, western Douglas, Clackamas, Multnomah, and Washington counties.

Key Points: 
  • The Connect Oregon network, powered by Unite Us, is a coordinated care network of health and social service providers.
  • Partners in the network are connected through the Unite Us Platform, an integrated, HI-TRUST-certified social care infrastructure helping providers and community-based organizations address social determinants of health and advance health equity.
  • "At Trillium, we are committed to ensuring our members have access to equitable, culturally sensitive care that addresses their whole health.
  • Trillium Community Health Plan serves Oregon Health Plan members through the CCO model, which began in 2012.

Trillium Engineering Announces New CEO

Retrieved on: 
星期四, 八月 18, 2022
UAS, United States Air Force Academy, Atmosphere, DynCorp, Growth, BEI, Abilene Christian University, Government, Rockwell Collins, Company, Air force academy, Program, Partnership, National Instruments, Management, Trillium

HOOD RIVER, Ore., Aug. 18, 2022 /PRNewswire/ -- Trillium Engineering, a leading designer and manufacturer of highly engineered camera gimbals for unmanned aerial systems ("UAS") performing mission-critical intelligence, surveillance and reconnaissance missions, is pleased to announce the appointment of Mark Mirelez as chief executive officer of the company. 

Key Points: 
  • Mark led the company during a period of highly successful growth which included the design, implementation and fielding of a broad and innovative product development program.
  • Prior to leading BEI, Mark held leadership roles at DynCorp International, Rockwell Collins, Norvell Electronics and National Instruments.
  • Mark holds a bachelor's degree from the United States Air Force Academy and a master's degree from Abilene Christian University.
  • "I am very excited to welcome Mark to Trillium" added Rob Gilchrist, co-founder and vice chairman of Trillium.

Automotive Cybersecurity Global Markets Report 2022: Analysis & Forecasts of Telematics, Body Control and Comfort, Infotainment, Powertrains 2016-2031 - ResearchAndMarkets.com

Retrieved on: 
星期四, 八月 18, 2022
Technology, Security, Continental AG, Infineon Technologies, Intelligence, Industry, Tesla, Technology, Growth, LG Electronics, RAT, Continental, Cyberattack, Harman International, Acquisition, Aptiv, NortonLifeLock, V2X, Electronics, Intel, Accident, Software, Internet, Lear Corporation, Argus Cyber Security, Organization, Medical device, Weapon, Road, Trillium, Cisco Systems

The automotive cybersecurity market consists of sales of automotive cyber security services by entities (organizations, sole traders, and partnerships) that help to reduce vehicle cyber-attacks and accidents.

Key Points: 
  • The automotive cybersecurity market consists of sales of automotive cyber security services by entities (organizations, sole traders, and partnerships) that help to reduce vehicle cyber-attacks and accidents.
  • The main types of automotive cybersecurity are network security, application security, endpoint security, wireless security, and cloud security.
  • The regions covered in the automotive cybersecurity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The automotive cybersecurity market research report is one of a series of new reports that provides automotive cybersecurity market statistics, including automotive cybersecurity industry global market size, regional shares, competitors with an automotive cybersecurity market share, detailed automotive cybersecurity market segments, market trends and opportunities, and any further data you may need to thrive in the automotive cybersecurity industry.

Oncolytics Biotech® Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

Retrieved on: 
星期四, 八月 11, 2022
TME, ESMO, Merck Group, Trillium, Survival, Oncolytics Biotech, ONC, Risk, CAR, Letrozole, AB, Breast, 2005 Tour de France, Stage 1 to Stage 11, Breast cancer, Mouse, Neoplasm, Industry, CFO, Cancer, Brain, TSX, Poster, European Society for Medical Oncology, Pfizer, Merck, PR, Patient, Pelareorep, Roche, Therapy, International, Company, Darmstadt, Prognosis, Acquisition, Pancreatic cancer, Data, Paclitaxel, NASDAQ, LINK, Skin cancer, Science Translational Medicine, Oncology, Progression-free survival, Immune system, Investor relations, Medical imaging, Pharmaceutical industry, Video game

(NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the second quarter ended June 30, 2022.

Key Points: 
  • (NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the second quarter ended June 30, 2022.
  • Operating expense for the second quarter of 2022 was $2.8 million, compared to $3.5 million for the second quarter of 2021.
  • R&D expense for the second quarter of 2022 was $3.2 million, compared to $3.2 million for the second quarter of 2021.
  • Net cash used in operating activities for the second quarter of 2022 was $6.9 million, compared to $6.8 million in the second quarter of 2021.